197 related articles for article (PubMed ID: 10371171)
21. Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis.
Khan MZ; Brandimarti R; Patel JP; Huynh N; Wang J; Huang Z; Fatatis A; Meucci O
AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1063-71. PubMed ID: 15585097
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4.
Herbein G; Mahlknecht U; Batliwalla F; Gregersen P; Pappas T; Butler J; O'Brien WA; Verdin E
Nature; 1998 Sep; 395(6698):189-94. PubMed ID: 9744279
[TBL] [Abstract][Full Text] [Related]
23. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway.
Popik W; Hesselgesser JE; Pitha PM
J Virol; 1998 Aug; 72(8):6406-13. PubMed ID: 9658081
[TBL] [Abstract][Full Text] [Related]
24. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
Yao Q; Compans RW; Chen C
Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
[TBL] [Abstract][Full Text] [Related]
25. Comodulation of CXCR4 and CD26 in human lymphocytes.
Herrera C; Morimoto C; Blanco J; Mallol J; Arenzana F; Lluis C; Franco R
J Biol Chem; 2001 Jun; 276(22):19532-9. PubMed ID: 11278278
[TBL] [Abstract][Full Text] [Related]
26. Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.
Vicenzi E; Bordignon PP; Biswas P; Brambilla A; Bovolenta C; Cota M; Sinigaglia F; Poli G
J Virol; 1999 Sep; 73(9):7515-23. PubMed ID: 10438841
[TBL] [Abstract][Full Text] [Related]
27. CXCR4 engagement is required for HIV-1-induced L-selectin shedding.
Wang J; Marschner S; Finkel TH
Blood; 2004 Feb; 103(4):1218-21. PubMed ID: 14576059
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4+ T cells.
Su SB; Gong W; Grimm M; Utsunomiya I; Sargeant R; Oppenheim JJ; Ming Wang J
J Immunol; 1999 Jun; 162(12):7128-32. PubMed ID: 10358157
[TBL] [Abstract][Full Text] [Related]
29. Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization.
Bachis A; Major EO; Mocchetti I
J Neurosci; 2003 Jul; 23(13):5715-22. PubMed ID: 12843275
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry.
Princen K; Hatse S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2003 Jan; 51(1):35-45. PubMed ID: 12500303
[TBL] [Abstract][Full Text] [Related]
31. Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium.
Huang MB; Bond VC
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):375-89. PubMed ID: 11141237
[TBL] [Abstract][Full Text] [Related]
32. Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactions.
Lum JJ; Schnepple DJ; Badley AD
AIDS; 2005 Jul; 19(11):1125-33. PubMed ID: 15990565
[TBL] [Abstract][Full Text] [Related]
33. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia.
Zheng J; Thylin MR; Ghorpade A; Xiong H; Persidsky Y; Cotter R; Niemann D; Che M; Zeng YC; Gelbard HA; Shepard RB; Swartz JM; Gendelman HE
J Neuroimmunol; 1999 Aug; 98(2):185-200. PubMed ID: 10430052
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 gp120 enhances giant depolarizing potentials via chemokine receptor CXCR4 in neonatal rat hippocampus.
Kasyanov A; Tamamura H; Fujii N; Xiong H
Eur J Neurosci; 2006 Mar; 23(5):1120-8. PubMed ID: 16553776
[TBL] [Abstract][Full Text] [Related]
35. CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes.
Balabanian K; Harriague J; Décrion C; Lagane B; Shorte S; Baleux F; Virelizier JL; Arenzana-Seisdedos F; Chakrabarti LA
J Immunol; 2004 Dec; 173(12):7150-60. PubMed ID: 15585836
[TBL] [Abstract][Full Text] [Related]
36. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
[TBL] [Abstract][Full Text] [Related]
37. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA
J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115
[TBL] [Abstract][Full Text] [Related]
38. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope.
Molina L; Grimaldi M; Robert-Hebmann V; Espert L; Varbanov M; Devaux C; Granier C; Biard-Piechaczyk M
Proteomics; 2007 Sep; 7(17):3116-30. PubMed ID: 17676665
[TBL] [Abstract][Full Text] [Related]
39. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
Jiang A; Fisher H; Pomerantz RJ; Dornburg R
Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
[TBL] [Abstract][Full Text] [Related]
40. N-linked glycosylation in the CXCR4 N-terminus inhibits binding to HIV-1 envelope glycoproteins.
Wang J; Babcock GJ; Choe H; Farzan M; Sodroski J; Gabuzda D
Virology; 2004 Jun; 324(1):140-50. PubMed ID: 15183061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
